Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gino Gums is a consumer healthcare company that specializes in the development and manufacturing of functional and medicated chewing gums. Based in Egypt, the company utilizes chewing gum as an innovative delivery system for active pharmaceutical ingredients and nutraceuticals, such as vitamins, minerals, and stimulants. Their product line includes Gino Energy, Gino Vitamin C, and Gino Zinc, which are designed to provide rapid absorption of nutrients through the oral mucosa. The company operates a dedicated manufacturing facility in 6th of October City, adhering to Good Manufacturing Practice (GMP) standards for medicated confectionery. Gino Gums primarily targets the Middle East and North Africa (MENA) region, offering convenient alternatives to traditional oral supplements. Their business model focuses on bridging the gap between the confectionery and pharmaceutical industries through specialized drug delivery technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gino Gums.